Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 45Unknown 11Recruiting 11Not yet recruiting 7Active not recruiting 4Terminated 3Withdrawn 2

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Conditions

Breast Neoplasms 1127Neoplasms 982Carcinoma, Non-Small-Cell Lung 900Prostatic Neoplasms 594Neoplasm Metastasis 528Leukemia, Myeloid, Acute 513Colorectal Neoplasms 491Lung Neoplasms 487Melanoma 485Multiple Myeloma 477Pancreatic Neoplasms 385Lymphoma 369Ovarian Neoplasms 368Recurrence 365Lymphoma, Non-Hodgkin 346Leukemia 339Leukemia, Lymphocytic, Chronic, B-Cell 321Precursor Cell Lymphoblastic Leukemia-Lymphoma 291Head and Neck Neoplasms 276Carcinoma, Renal Cell 276Brain Neoplasms 273Carcinoma, Hepatocellular 261Glioblastoma 249Lymphoma, Large B-Cell, Diffuse 244Myelodysplastic Syndromes 242Squamous Cell Carcinoma of Head and Neck 241Lymphoma, Follicular 236Colonic Neoplasms 214Stomach Neoplasms 200Rectal Neoplasms 190

Interventions

Pregabalin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Neuralgia × Clear all
NCT04287075 2024-03-26

Rethink Pain

Axogen Corporation

Terminated
8 enrolled

Neuralgia, Neuroma, Peripheral Nervous System Diseases, Peripheral Nerve Injuries, Chronic Pain

NCT01293851 2019-12-05

Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage

National Institutes of Health Clinical Center (CC)

Terminated
3 enrolled

Neoplasms, Neuralgia, Neurotoxicity Syndromes

NCT02924675 2019-10-14

LYRORL

University Hospital, Lille

Phase 2 Terminated
42 enrolled

Earache, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡